World Wires · story 13142 · unverified · 1 source(s)

BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter

SUNNYVALE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- BioCardia ® , Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the t

Open in the desk

Coverage

• BioCardia Files Revised De Novo Pre-Submission for FDA Approval of Helix™ Catheter GlobeNewswire: public companies · tier D · clear net · 2026-10-01 13:15 UTC

What this site indexes